| P50 | author | Vijaya Raj Bhatt | Q84159877 |
| P2093 | author name string | Prajwal Dhakal | |
| | Kirk W Foster | |
| | Ketki K Tendulkar | |
| | Osama Elsallabi | |
| P2860 | cites work | Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 |
| | Successful treatment of acute thrombotic microangiopathy by eculizumab after combined lung and kidney transplantation | Q45818643 |
| | Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy. | Q45932533 |
| | Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys | Q46702750 |
| | Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy. | Q50622232 |
| | A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury | Q26992169 |
| | Role of flexible bronchoscopy in lung transplantation | Q33221355 |
| | Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease. | Q33256286 |
| | Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities | Q33335306 |
| | The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation. | Q33337105 |
| | Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT). | Q33343954 |
| | Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liver | Q33344003 |
| | Transplantation-associated thrombotic microangiopathy: twenty-two years later | Q33345369 |
| | Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma | Q33359551 |
| | Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion | Q33364155 |
| | Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation | Q33366979 |
| | Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation | Q33367451 |
| | Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants. | Q33368614 |
| | Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment | Q33371313 |
| | Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group | Q33373889 |
| | Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting? | Q33375739 |
| | Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis | Q33382787 |
| | Thrombotic microangiopathy in haematopoietic stem cell transplantation: diagnosis and treatment | Q33383355 |
| | Intestinal perforation secondary to haematopoietic stem cell transplant associated thrombotic microangiopathy | Q33384648 |
| | Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange | Q33386308 |
| | Chronic kidney disease, thrombotic microangiopathy, and hypertension following T cell-depleted hematopoietic stem cell transplantation | Q33388255 |
| | How I treat patients with thrombotic thrombocytopenic purpura: 2010 | Q33391206 |
| | Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT. | Q33391308 |
| | Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation | Q33391457 |
| | Successful early intervention for hyperacute transplant-associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation | Q33392710 |
| | Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy | Q33395413 |
| | Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report | Q33395870 |
| | Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation | Q33396637 |
| | Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. | Q33396969 |
| | Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer | Q33399187 |
| | Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy? | Q33402385 |
| | Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxis | Q33403897 |
| | Tacrolimus-associated thrombotic microangiopathy in a lung transplant recipient | Q33405793 |
| | Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy | Q33407913 |
| | Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome | Q33408211 |
| | Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changes | Q33408360 |
| | Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy | Q33408788 |
| | Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy. | Q33412325 |
| | Eculizumab for drug-induced de novo posttransplantation thrombotic microangiopathy: A case report | Q33413137 |
| | Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP. | Q33414383 |
| | Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults | Q33415603 |
| | Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches | Q33415815 |
| | Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options | Q33417613 |
| | De novo thrombotic microangiopathy after non-renal solid organ transplantation | Q33417893 |
| | Albuminuria in hematopoietic cell transplantation patients: prevalence, clinical associations, and impact on survival | Q33570908 |
| | The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria | Q34567835 |
| | Cyclosporin A impairs the secretion and activity of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeat). | Q36492812 |
| | Infection in solid-organ transplant recipients | Q37038203 |
| | Chronic kidney disease after pediatric hematopoietic cell transplant | Q37045941 |
| | Banff 2011 Meeting report: new concepts in antibody-mediated rejection | Q37058043 |
| | Renal pathology at autopsy in patients who died after hematopoietic stem cell transplantation | Q38449855 |
| P433 | issue | 1 | |
| P921 | main subject | stem cell transplantation | Q65592366 |
| P304 | page(s) | 12-20 | |
| P577 | publication date | 2015-08-02 | |
| P1433 | published in | Clinical and Applied Thrombosis-Hemostasis | Q5133805 |
| P1476 | title | Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy | |
| P478 | volume | 22 | |